Two new JAMA Network Open studies link popular diabetes and weight loss drugs, including Ozempic and Mounjaro, to a slightly ...

As weight-loss drugs are gaining popularity among Indian diabetes and obesity stricken patients in India, new research ...

Ascletis Pharma, Inc. ( ($HK:1672) ) just unveiled an update. Ascletis Pharma Inc. announced promising preclinical results for its ...

In June 2025, Fractyl presented preclinical data at the American Diabetes Association’s 85th Scientific Sessions that showed ...

The FDA said it's taking action to protect patients from unapproved animal-derived thyroid medications and expressed concern over the use of unapproved GLP-1 receptor agonists for weight loss, such as ...

Overview - As demand for GLP-1 drugs continues to skyrocket, federal and state agencies are turning their attention to the GLP-1 ...

ACROSS the UK, waistlines are shrinking – and it’s not down to willpower alone. While Ozempic-like weight-loss jabs have been ...

SOON after losing 4st with skinny jabs, Jane Fennah’s eyes turned yellow – and she needed an organ removed. “I thought I was ...

The obesity market still only has two clear leaders with approved GLP-1 medications, and frontrunners Eli Lilly and Novo ...

New studies indicate that weight-loss drugs may lead to serious eye diseases and vision loss in some individuals, prompting ...

The partnership means that Apple's fitness and wellness service will be made available to all members who enrol onto ...

New studies confirm a small increased risk of serious eye conditions and vision loss in people taking weight-loss drugs like Ozempic, Wegovy, and Mounjaro.